Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05163223
Title Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast Cancer (Cornerstone001)
Acronym Cornerstone001
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Aston Sci. Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.